Dr Richard Booton, Consultant Respiratory Physician
Dr Richard Booton
Consultant Respiratory Physician
Dr Richard Booton MBChB, PhD, FRCP
Consultant Respiratory Physician
Dr Booton is a Consultant Respiratory Physician
Areas of expertise
- Lung cancer
- Thoracic oncological surgery
- Clinical care in thoracic oncology
- Advanced bronchoscopy
- Asthma
Make an appointment
Address
-
HCA UK at The Wilmslow Hospital
52-54 Alderley Road Wilmslow, London, SK9 1NY
-
The Christie Private Care
Wilmslow Road, Manchester, M20 4BX
About Dr Richard Booton
GMC number: 3677320
Year qualified: 1992
Place of primary qualification: University of Leeds
Dr Richard Booton is a Consultant Respiratory Physician at the North West Lung Centre and serves as the clinical director for lung cancer and thoracic surgery at Wythenshawe Hospital. He also sees patients privately at The Christie Private Care and The Wilmslow Hospital. Additionally, Professor Booton holds the position of honorary chair in respiratory medicine at the University of Manchester.
Dr Booton graduated from the University of Leeds and completed his higher specialist training in the North West. He then pursued a fellowship in thoracic oncology at The Christie Hospital and the Paterson Institute for Cancer Research under the mentorship of Professor Nick Thatcher, earning a PhD in 2006. He is the programme director for the award-winning RAPID screening programme, which aims to provide patients with a clear diagnosis of lung cancer within seven days.
His clinical research interests focus on thoracic oncology, advanced bronchoscopy, and lung cancer screening. Dr Booton is a member of the MesoTRAP Trial Steering Group and serves as the principal investigator for the EARL and ELUSIVE multicentre studies in Manchester. He is also a co-investigator for the Yorkshire Lung Screening Trial and co-chair of the YLST Biomarker Subgroup. To date, he has published over 70 peer-reviewed articles.
Dr Booton is affiliated with several professional organisations, including the British Thoracic Oncology Group, the Council of Regents, and the Communications Committee for the International Association for the Study of Lung Cancer. He is also a member of the Clinical Advisory Group of the National Lung Cancer Audit, the NHSE Expert Advisory Group on Lung Cancer Screening, and the NHSE National Delivery Group for Lung Health Checks.
Diseases, Medical Tests, and Treatments
- Lung Cancer Screening
- Bronchoscopy
- Lung Cancer
- Thoracic Oncology
Dr Booton has been dedicated to advancing the field of respiratory medicine since his appointment and continues to contribute significantly to clinical research and patient care.
Areas of expertise
- Pre-malignancy
- Lung cancer screening
- Staging
- Recurrent disease
- Respiratory medicine
- Thoracic oncology
- Asthma
- Chest Medicine
- Lung Cancer
- Lung disease
- Respiratory pathology
Professional memberships
Articles by Dr Richard Booton
Yorkshire lung screening trial (ylst): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose ct screening for lung cancer versus usual care in a targeted population at risk
P1.05-029 sabrtooth-a feasibility study of sabr compared to surgery in patients with peripheral stage i nsclc considered to be at higher risk from surgery
Fc-optimized anti-cd25 depletes tumor-infiltrating regulatory t cells and synergizes with pd-1 blockade to eradicate established tumors
Analysis of lung cancer risk model (plco m2012 and llp v2 ) performance in a community-based lung cancer screening programme
Second round results from the manchester ‘lung health check’ community-based targeted lung cancer screening pilot
Endobronchial ultrasound-guided transbronchial needle aspiration for pd-l1 testing in non-small cell lung cancer
“to know or not to know…?” push and pull in ever smokers lung screening uptake decision‐making intentions
Sequential screening for lung cancer in a high-risk group: randomised controlled trial
Allele-specific hla loss and immune escape in lung cancer evolution
Kras induces lung tumorigenesis through micrornas modulation
